Amwill Health Care IPO

Founded in August 2017, Amwill Health Care Limited is a derma-cosmetic development company that partners with contract manufacturers, distributors, and third-party product development agencies, enhancing its capabilities in manufacturing, packaging, and distribution. The company’s product range focuses on two categories: generic dermatological solutions and targeted treatments for skin conditions. Amwill operates primarily in Karnataka, Andhra Pradesh, and Telangana, aiming to establish a strong presence before expanding. Their products address acne, fungal infections, anti-ageing, pigmentation, scabies, perspiration, trichology, and vitiligo. As of April 30, 2024, the company employs 59 people, including 31 in marketing.

IPO Strengths

• Diverse product portfolio supported by strong product formulation capabilities

• High-quality product development through partnerships with contract manufacturers and prototype developers

• Asset-light business model, ensuring greater flexibility and operational efficiency

• Experienced management team with proven project management and implementation expertise

Amwill Healthcare IPO Key Financials (in ₹ lakhs)

Particulars	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	1239.43	658.75	828.99
Revenue	3016.63	2761.32	1799.94
Profit After Tax	311.44	257.37	(99.80)
Reserves and Surplus	457.23	145.79	(111.58)
Total Borrowings	–	–	–

Amwill Healthcare Limited Upcoming IPO Details

Category	Details
Issue Type	Book Built Issue IPO
Total Issue Size	Fresh Issue: 44,03,600 shares (aggregating up to ₹ 48.88 Cr) Offer for Sale: 10,00,000 shares (aggregating up to ₹11.10 Cr)
Price Range	₹105 to ₹111 per share
Lot Size	1200 Shares
Face Value	₹10 per share
Listing Exchange	SME, BSE
Pre-IPO Shareholding	1,56,00,000 shares
Post-IPO Shareholding	2,00,03,600 shares
Market Marker	2,71,200 shares (Globalworth Securities Limited)

Amwill Healthcare IPO Important Dates

IPO Activity	Date
IPO Open Date	5 February 2025
IPO Close Date	7 February 2025
Basis of Allotment	10 February 2025
Refunds Initiation	11 February 2025
Credit of Shares to Demat	11 February 2025
Listing Date	12 February 2025

Amwill Healthcare IPO Lots

Application	Lots	Shares	Amount
Retail (Min)	1	1200	₹1,33,200
Retail (Max)	1	1200	₹1,33,200
HNI (Min)	2	2000	₹2,66,400

Amwill Healthcare IPO Lead Managers

Lead Managers

Unicorn Capital Service Private Limited

Amwill Healthcare Limited IPO Valuation Overview

KPI	Value
Earnings Per Share (EPS)	2.00
Price/Earnings (P/E) Ratio	TBD
Return on Net Worth (RoNW)	67.67%
Net Asset Value (NAV)	2.95
Return on Equity	67.67%
Return on Capital Employed (ROCE)	83.32%
EBITDA Margin	14.24%
PAT Margin	10.32%
Debt to Equity Ratio	–

Amwill Healthcare IPO Peer Group Comparison

Name of the Company	Face Value (₹)	Revenue (₹ in Lakhs)	Basic EPS (₹)	P/E	Return on Net Worth (%)	NAV (₹)
Amwill Health Care Limited	10	3,016.63	2.00	[●]	67.67%	2.95
Vaishali Pharma Limited	10	6,966.28	6.26	28.47	16.29%	13.18
Trident Lifeline Limited	10	3,169.22	6.23	26.81	13.18%	38.43

Objectives of the Proceeds

• Funding of working capital requirements, ₹2500 lakhs

• Towards marketing and brand building activities, ₹500 lakhs

• Meeting general corporate expenses